CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2019

Altmetric Badge

Mentioned by

twitter: 1 tweeter

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 13 Mendeley

Summary Twitter Facebook Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis

Article in Frontiers in Immunology (January 2023)

CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis

Article in Frontiers in Immunology (January 2023)

Cytokines/chemokines and immune checkpoint molecules in anti-leucine-rich glioma-inactivated 1 encephalitis

Article in Neurological Sciences (November 2022)